KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,093,000 | +54550.0% | 78,083 | +66637.6% | 0.00% | – |
| Q2 2021 | $2,000 | -99.6% | 117 | -99.4% | 0.00% | -100.0% |
| Q1 2021 | $529,000 | -94.1% | 18,717 | -93.2% | 0.00% | -94.4% |
| Q4 2020 | $8,966,000 | +5.4% | 274,512 | -1.1% | 0.02% | -10.0% |
| Q3 2020 | $8,504,000 | +169980.0% | 277,561 | +98676.2% | 0.02% | – |
| Q2 2020 | $5,000 | +400.0% | 281 | +226.7% | 0.00% | – |
| Q1 2020 | $1,000 | -99.7% | 86 | -99.7% | 0.00% | -100.0% |
| Q4 2019 | $346,000 | -89.6% | 25,128 | -88.6% | 0.00% | -87.5% |
| Q3 2019 | $3,330,000 | +6985.1% | 219,490 | +9015.0% | 0.01% | – |
| Q2 2019 | $47,000 | +1466.7% | 2,408 | +1386.4% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 162 | -8.0% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 176 | +282.6% | 0.00% | – |
| Q3 2018 | $1,000 | -99.5% | 46 | -99.6% | 0.00% | -100.0% |
| Q2 2018 | $206,000 | -17.9% | 11,309 | -15.5% | 0.00% | 0.0% |
| Q1 2018 | $251,000 | +24.9% | 13,391 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $201,000 | – | 13,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |